Top story

RFK Jr. to Allow Broad Use of Unapproved Peptide Injections

In a unilateral declaration by the health secretary, several injections promoted by online influencers will become widely available. The F.D.A. had advised against the move.

Read full story

Monthly News Roundup - December 2025

Drugs.com - News for Health Professionals

Wed, 31 Dec 2025

Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism

Drugs.com - New Drug Applications

Wed, 31 Dec 2025

FDA Approves Yartemlea (narsoplimab-wuug) for the Treatment of Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy

Drugs.com - New Drug Approvals

Wed, 24 Dec 2025

MediNatura New Mexico, Inc. Issues Voluntary Nationwide Recall of ReBoost Nasal Spray Due to Microbial Contamination

Drugs.com - FDA MedWatch Drug Alerts

Wed, 10 Dec 2025

International Day of Persons with Disabilities Day 2025

WHO Regional Office for Africa

By mtabi@who.int - Tue, 02 Dec 2025

Postpartum Prescription of GLP-1 Drugs Has Increased Sharply, Study Finds

The New York Times - Drugs & Pharmaceuticals

By Roni Caryn Rabin - Wed, 26 Nov 2025

U.S. Announces Negotiated Prices for 15 Drugs Under Medicare

The New York Times - Drugs & Pharmaceuticals

By Rebecca Robbins - Wed, 26 Nov 2025

FDA Grants Accelerated Approval for Voyxact (sibeprenlimab-szsi) for the Reduction of Proteinuria in Adults with Primary Immunoglobulin A Nephropathy

Drugs.com - New Drug Approvals

Wed, 26 Nov 2025

FDA Grants Accelerated Approval for Voyxact (sibeprenlimab-szsi) for the Reduction of Proteinuria in Adults with Primary Immunoglobulin A Nephropathy (IgAN) at Risk for Disease Progression

Drugs.com - New Drug Approvals

Wed, 26 Nov 2025